1137. Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung).
Kim SJ, Kim JW, Oh DY, Han SW, Lee SH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ.
Am J Clin Oncol. 2011 Jun 8. [Epub ahead of print]Link
1136. Down-regulation of P-cadherin with PF-03732010 inhibits cell migration and tumor growth in gastric cancer.
Park J, Park E, Han SW, Im SA, Kim TY, Kim WH, Oh DY, Bang YJ.
Invest New Drugs. 2011 Jul 1. [Epub ahead of print]Link
1135. Evaluation of the Antitumor Effects and Mechanisms of PF00299804, a Pan-HER Inhibitor, Alone or in Combination with Chemotherapy or Targeted Agents in Gastric Cancer.
Nam HJ, Ching KA, Kan J, Kim HP, Han SW, Im SA, Kim TY, Christensen JG, Oh DY, Bang YJ.
Mol Cancer Ther. 2012 Feb;11(2):439-51. Epub 2011 Dec 1.Link
1134. NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations.
Park E, Park J, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Int J Oncol. 2012 Apr;40(4):1259-66. doi: 10.3892/ijo.2011.1290. Epub 2011 Dec 8.Link
1133. The irreversible pan-HER inhibitor PF00299804 alone or combined with gemcitabine has an antitumor effect in biliary tract cancer cell lines.
Nam HJ, Kim HP, Yoon YK, Song SH, Min AR, Han SW, Im SA, Kim TY, Oh DY, Bang YJ.
Invest New Drugs. 2011 Dec 25. [Epub ahead of print]Link
1132. High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Kim K, Chie EK, Wu HG, Kim SG, Lee SH, Kang GH, Hyun CL, Ha SW.
Int J Colorectal Dis. 2011 Aug;26(8):1019-23. Epub 2011 Mar 19.Link
1131. Immunohistochemical study identifying prognostic biomolecular markers in nasopharyngeal carcinoma treated by radiotherapy.
Kim YJ, Go H, Wu HG, Jeon YK, Park SW, Lee SH.
Head Neck. 2011 Oct;33(10):1458-66. doi: 10.1002/hed.21611. Epub 2010 Nov 4.Link
1130. Postoperative radiotherapy for completely resected stage II or III thymoma.
1129. Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.
Kim JW, Kim BS, Bang SM, Kim I, Kim DH, Kim WS, Yang DH, Lee JJ, Lee JH, Kim JS, Sohn SK, Yhim HY, Kwak JY, Yoon SS, Lee JS, Park S, Kim BK; Korean Society of Blood and Marrow Transplantation.
Ann Hematol. 2011 Dec;90(12):1409-18. Epub 2011 Apr 6.Link
1128. Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro.
Jee HG, Lee KE, Kim JB, Shin HK, Youn YK.
Phytother Res. 2011 Nov;25(11):1623-8. doi: 10.1002/ptr.3397. Epub 2011 Mar 17.Link